← Browse by Condition
Medical Condition

anorectal cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06669572 Phase 2
Recruiting

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

Enrollment
35 pts
Location
United States
Sponsor
University of Chicago
View Trial →